Hepatitis C virus nonstructural protein 5A inhibits tumor necrosis factor-α-mediated apoptosis in Huh7 cells

被引:18
作者
Miyasaka, Y
Enomoto, N
Kurosaki, M
Sakamoto, N
Kanazawa, N
Kohashi, T
Ueda, E
Maekawa, S
Watanabe, H
Izumi, N
Sato, C
Watanabe, M
机构
[1] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Bunkyo Ku, Tokyo 1138519, Japan
[2] Tokyo Med & Dent Univ, Dept Analyt Hlth Sci, Bunkyo Ku, Tokyo 1138519, Japan
[3] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan
关键词
D O I
10.1086/379253
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To analyze the influence of hepatitis C virus nonstructural protein 5A ( NS5A) on apoptosis, we established Huh7 cells that stably express NS5A, and induced apoptosis using tumor necrosis factor ( TNF) - alpha. The viability of control Huh7 cells was reduced to 40%, compared with untreated cells, after TNF- alpha treatment, whereas that of Huh7- NS5A cells was reduced only to 80%. DNA fragmentation also decreased to < 50% in Huh7-NS5A compared with control cells. Nuclear factor - κB activation was the same in both cell types, whereas caspase- 8, - 9, and - 3 activity was decreased in Huh7- NS5A cells, compared with control cells, which indicates that the inhibition of caspase- 8 activation is responsible for the antiapoptotic effect of the NS5A protein. The coexpression of NS5A did not inhibit apoptosis induced by caspase- 8 or Fas- associating death domain protein expression. These findings suggest that the NS5A protein inhibits the apoptotic effect of TNF- α upstream of caspase- 8 in the apoptosis cascade.
引用
收藏
页码:1537 / 1544
页数:8
相关论文
共 51 条
[1]  
Ando K, 1997, J IMMUNOL, V158, P5283
[2]   Interferon-stimulated gene expression and hepatitis C viral dynamics during different interferon regimens [J].
Asahina, Y ;
Izumi, N ;
Uchihara, M ;
Noguchi, O ;
Nishimura, Y ;
Inoue, K ;
Ueda, K ;
Tsuchiya, K ;
Hamano, K ;
Itakura, J ;
Miyake, S .
JOURNAL OF HEPATOLOGY, 2003, 39 (03) :421-427
[3]   DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection [J].
Bigger, CB ;
Brasky, KM ;
Lanford, RE .
JOURNAL OF VIROLOGY, 2001, 75 (15) :7059-7066
[4]   Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence [J].
Cerny, A ;
Chisari, FV .
HEPATOLOGY, 1999, 30 (03) :595-601
[5]   Monitoring of viral levels during therapy of hepatitis C [J].
Davis, GL .
HEPATOLOGY, 2002, 36 (05) :S145-S151
[6]   Optimal therapy of hepatitis C [J].
Di Bisceglie, AM ;
Hoofnagle, JH .
HEPATOLOGY, 2002, 36 (05) :S121-S127
[7]  
Dumoulin FL, 2001, J HUMAN VIROL, V4, P195
[8]   Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection [J].
Enomoto, N ;
Sakuma, I ;
Asahina, Y ;
Kurosaki, M ;
Murakami, T ;
Yamamoto, C ;
Ogura, Y ;
Izumi, N ;
Marumo, F ;
Sato, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (02) :77-81
[9]   COMPARISON OF FULL-LENGTH SEQUENCES OF INTERFERON-SENSITIVE AND RESISTANT HEPATITIS-C VIRUS 1B - SENSITIVITY TO INTERFERON IS CONFERRED BY AMINO-ACID SUBSTITUTIONS IN THE NS5A REGION [J].
ENOMOTO, N ;
SAKUMA, I ;
ASAHINA, Y ;
KUROSAKI, M ;
MURAKAMI, T ;
YAMAMOTO, C ;
IZUMI, N ;
MARUMO, F ;
SATO, C .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :224-230
[10]   Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action [J].
Gil, J ;
Esteban, M .
APOPTOSIS, 2000, 5 (02) :107-114